Skip to the guide Seattle, Washington · A guide to care Source tools Seattle peptide guide Costs & cover All chapters Start The words Washington checks Visit questions Costs & cover Before treatment Source tools Back to the starting card Source tools # Put the claim beside the record. A polished offer can leave the main question unanswered. Match each claim to the record that can support it. Registration An official record that a business has signed up or listed a product; it does not mean the product is approved. ## Different records answer different questions. A licence concerns the person or pharmacy. Product approval concerns the medicine. A registration is another kind of record. Registering a business or listing a medicine did not establish approval, as the Food and Drug Administration (FDA) explained on September 26, 2026. An NDC (National Drug Code) identifies an entry for a product in FDA’s drug catalogue. A code or listing does not mean FDA approved the product. Ask which exact record supports the claim being made. Then read what that record can actually establish. Match the question to the record Who can provide care? State credential record What product was reviewed? FDA approval and label record What concerns were raised? Dated agency letters or alerts Evidence for this chapter FDA: the scope and limits of approval As of September 26, 2026, registering a business did not show that FDA had approved its products. FDA: drug codes and listings A code is not a substitute for checking the product’s approval. Public record A source you can read directly when checking an offer. ## Open the tool that fits the question. Check a Washington credential Search the actual clinician or pharmacy name. Understand an approval claim Read FDA’s explanation of what it approves. Read the compounding and shortage updates Check the date and the exact product named. Search FDA letters Use the business name, then read the date and any later response. This file contains the questions shown on the starting card. JSON is a plain text format that also has punctuation for computers to read. Read the medicine, care, and cost questions (JSON file) Evidence for this chapter Washington: how to use the credential record State lookup guidance as of September 30, 2026. FDA: public letters and later updates Letters are dated records, and later exchanges can change the issues described. Adverse event An unwanted health problem reported while someone is using a medical product. ## Read what the record leaves uncertain. An FDA letter describes the agency’s concerns on its issue date; it is not a court’s final finding. The absence of a letter may mean the business has never undergone review. FDA also says that a reported health problem establishes neither that a medicine caused it nor how often the problem happens. Keep the questions apart: what is known about the product, what the rules permit, and what fits your own care discussion. For a personal decision, bring the exact name and the unanswered question to a licensed clinician. Evidence for this chapter FDA: how to read problem reports A report calls for a closer look. It does not prove what caused a health problem or how often it happens. FDA: limits of a letter A later response may change the concerns described in a letter. Return to the starting card Seattle peptide treatment, in plain words. Seattle Peptide Treatment helps readers understand care offers. This site provides neither clinical care nor medicines. Visit questions Source tools Text edition